Title of article :
Sleep Disorders in ESRD Patients Undergoing Hemodialysis
Author/Authors :
Abassi، Mohammad Reza نويسنده Abassi , , Safavi، Amin نويسنده Department of Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Safavi, Amin , Haghverdi، Masoumeh نويسنده Department of Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Haghverdi, Masoumeh , Saedi، Babak نويسنده Tehran University of Medical Sciences,Department of otorhinolaryngology ,
Issue Information :
ماهنامه با شماره پیاپی 0 سال 2016
Pages :
9
From page :
176
To page :
184
Abstract :
Kidney failure affects different aspects of normal life. Among different manifestations, sleep problem can be considered as a common complaint of ESRD (End Stage Renal Disease) patients. In this study, we aimed to investigate the interrelationship between sleep disorders in ESRD patients and their characteristics. Through a cross-sectional study (2010-2011), 88 ESRD patients undergoing maintenance hemodialysis thrice weekly were recruited to enter the study. We used a self-administered questionnaire into which the data were reflected. The patients selected their specific sleep disorders using a nine-item scale while the Epworth Sleepiness Scale (ESS) determined both the presence and severity of sleep disorders. The data was finally analyzed with their baseline characteristics, dialysis characteristics, medication/stimulants use, and clinical and biochemical parameters. Over 95% of the patients had, at least, one specific sleep disorder while the ESS revealed 36.36% of patients as normal, 59.09% as having mild sleep disorders, and 4.54% as having moderate to severe sleep disorders. Sleep disorders were significantly correlated with older ages (P=0.035), dialysis dose (P=0.001), blood creatinine levels (P=0.037), upper airways obstruction (P=0.035), hepatomegaly (P=0.006), hepatic failure (P=0.001), higher blood TSH levels (P=0.039), history of hypothyroidism (P=0.005), and the use of levodopa (P=0.004), anti-hypertensive medications (P=0.006), benzodiazepines (P=0.006), Eprex (Erythropoietin) (P=0.001), Venofer (Iron Sucrose Injection) (P=0.013), and phosphate-binders agents (P=0.018). Sleep disorders are common findings among ESRD patients and seem to be a more complicated issue than a simple accumulation of the wastes products in the body. Whatever the causes of sleep disorders are, disorder-specific treatments should be considered.
Journal title :
Acta Medica Iranica
Serial Year :
2016
Journal title :
Acta Medica Iranica
Record number :
2390628
Link To Document :
بازگشت